Abnormal behaviour and Multiple sclerosis relapse

Summary:

Multiple sclerosis relapse is reported only by a few people with Abnormal behaviour.

The study analyzes which people have Multiple sclerosis relapse with Abnormal behaviour. It is created by eHealthMe based on 2 people who have Multiple sclerosis relapse and Abnormal behaviour from the Food and Drug Administration (FDA), and is updated regularly.

What is Abnormal behaviour?

Abnormal behaviour is found to be associated with 1,899 drugs and 2,151 conditions by eHealthMe. Check the latest studies of Abnormal behaviour.

What is Multiple sclerosis relapse?

Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) is found to be associated with 1,112 drugs and 930 conditions by eHealthMe. Check the latest studies of Multiple sclerosis relapse.

On Oct, 29, 2025

2 people who have Abnormal Behaviour and Multiple Sclerosis Relapse are studied.

Would you have Multiple sclerosis relapse when you have Abnormal behaviour?

Gender of people who have Abnormal Behaviour and experienced Multiple Sclerosis Relapse *:

female: 50 %
male: 50 %

Age of people who have Abnormal Behaviour and experienced Multiple Sclerosis Relapse *:

Common co-existing conditions for these people *:

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 50.00%

Common drugs taken by these people *:

Risperidone: 1 person, 50.00%
Methylprednisolone: 1 person, 50.00%
Fingolimod: 1 person, 50.00%
Depakene: 1 person, 50.00%
Avonex: 1 person, 50.00%

Common symptoms for these people *:

Vision Blurred: 1 person, 50.00%
Nausea (feeling of having an urge to vomit): 1 person, 50.00%
Malaise (a feeling of general discomfort or uneasiness): 1 person, 50.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 50.00%
Cardiac Arrest: 1 person, 50.00%
Bradycardia (abnormally slow heart action): 1 person, 50.00%
Blindness: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Multiple sclerosis relapse?

Check whether Multiple sclerosis relapse is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Multiple sclerosis relapse and Abnormal behaviour, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.